US 11,951,171 B2
Polypeptide EXP and its drug delivery system as well as extracellular vesicle extraction
Haifang Yin, Tianjin (CN); Ning Ran, Tianjin (CN); Caorui Lin, Tianjin (CN); and Xianjun Gao, Tianjin (CN)
Assigned to TIANJIN MEDICAL UNIVERSITY, Tianjin (CN)
Appl. No. 17/053,244
Filed by TIANJIN MEDICAL UNIVERSITY, Tianjin (CN)
PCT Filed Dec. 18, 2019, PCT No. PCT/CN2019/126161
§ 371(c)(1), (2) Date Nov. 5, 2020,
PCT Pub. No. WO2021/088214, PCT Pub. Date May 14, 2021.
Claims priority of application No. 201911084784.X (CN), filed on Nov. 8, 2019.
Prior Publication US 2022/0211856 A1, Jul. 7, 2022
Int. Cl. A61K 47/64 (2017.01); C07K 7/08 (2006.01); C12N 5/00 (2006.01); C12N 5/078 (2010.01)
CPC A61K 47/64 (2017.08) [C07K 7/08 (2013.01); C12N 5/0634 (2013.01); C12N 2509/00 (2013.01)] 26 Claims
 
1. A polypeptide EXP, comprising the amino acid sequence of SEQ ID NO: 1.